na

Dr. Natalie Put and Prof. Michel Delforge highlight the fact that Blenrep provides a rapid and durable response even in high-risk patients with an excellent quality of life.1-5

Speakers

Dr. Natalie Put Prof. Michel Delforge

20
20
na

Dr. Natalie Put and Prof. Michel Delforge highlight the fact that Blenrep provides a rapid and durable response even in high-risk patients with an excellent quality of life.1-5

Speakers

Dr. Natalie Put Prof. Michel Delforge

20
20

FF/UMEC/VI vs UMEC/VI

42%

(95% CI: 12, 62); p=0.011

Absolute risk difference = 0.68%

Maladies infectieuses

Bienvenue sur la page médicale dédiée aux professionnels de santé au sujet des maladies infectieuses à prévention vaccinale.

Maladies infectieuses

Bienvenue sur la page médicale dédiée aux professionnels de santé au sujet des maladies infectieuses à prévention vaccinale.

  • Monday 9 October  

    Click the 'Open in new tab' button below each image to view the poster or presentation

    Higher Chronic Obstructive Pulmonary Disease (COPD) Assessment Test scores are associated with pulmonary rehabilitation and pulmonology visits among patients with COPD

    Gaeckle N, Corazalla E, Liberman JN, Kelloway J, Kahle-Wrobleski K, Paczkowski R, Parab P, Ruetsch C

    Dyspnoea is the most common COPD symptom and has a considerable impact on daily life.2-4

    A cross-sectional, observational study in 17 countries (N= 2441) identified the daily activities that patients felt were most affected by COPD symptoms.3

    Proportion of patients with daily activities most affected by COPD symptoms

    image-showing-the-proportion-of-patients-with-daily-activities-most-affected-by-COPD-symptoms.-82.5-percent-of-patients-found-going-up-and-down-stairs-was-affected,-56.9-percent-found-heavy-household-duties-affected,-43.1-percent-found-going-shopping-was-affected,-and-35.9-percent-found-doing-sports-or-hobbies-was-affected

    Dyspnoea is the most common COPD symptom and has a considerable impact on daily life.2-4

    A cross-sectional, observational study in 17 countries (N= 2441) identified the daily activities that patients felt were most affected by COPD symptoms.3

    Proportion of patients with daily activities most affected by COPD symptoms

    image-showing-the-proportion-of-patients-with-daily-activities-most-affected-by-COPD-symptoms.-82.5-percent-of-patients-found-going-up-and-down-stairs-was-affected,-56.9-percent-found-heavy-household-duties-affected,-43.1-percent-found-going-shopping-was-affected,-and-35.9-percent-found-doing-sports-or-hobbies-was-affected

  • Dyspnoea is the most common COPD symptom and has a considerable impact on daily life.2-4

    Dyspnoea is the most common COPD symptom and has a considerable impact on daily life.2-4

    A cross-sectional, observational study in 17 countries (N= 2441) identified the daily activities that patients felt were most affected by COPD symptoms.3

    Proportion of patients with daily activities most affected by COPD symptoms

    image-showing-the-proportion-of-patients-with-daily-activities-most-affected-by-COPD-symptoms.-82.5-percent-of-patients-found-going-up-and-down-stairs-was-affected,-56.9-percent-found-heavy-household-duties-affected,-43.1-percent-found-going-shopping-was-affected,-and-35.9-percent-found-doing-sports-or-hobbies-was-affected

  • High symptom burden and exacerbations are key contributors to the burden of COPD5

    Three-year all-cause mortality in patients with COPD by GOLD 2017 subgroup stratified by symptoms and exacerbation risk showed all-cause mortality increased with increasing exacerbations and dyspnoea.5

    line-graph-showing-all-cause-mortality-over-3-years-in-patients-with-COPD-by-GOLD-2017-subgroup-stratified-by-symptoms-and-exacerbation-risk.-At-3-years-all-cause-cumulative-mortality-was-8.9-percent-for-GOLD-Group-A,-15.5-percent-for-GOLD-Group-C,-23.2-percent-for-GOLD-Group-B,-and-35.3-percent-for-GOLD-Group-D

    Adapted with permission from Gedebjerg A, Szépligeti SK, Wackerhausen LH, et al. Prediction of mortality in patients with chronic obstructive pulmonary disease with the new Global Initiative for Chronic Obstructive Lung Disease 2017 classification: a cohort study. Lancet Respir Med. 2018;6:204-212.

    Therapy icon

    Inhaled maintenance therapy is a cornerstone of COPD treatment2

    Inhaler icon

    Choice of inhaler device and appropriate inhaler technique are important considerations to improve outcomes in patients with COPD2